Tradeweb Delivers: Street Lifts Targets After Earnings Beat

Tradeweb Markets closed out its earnings week with the stock up 22% over the past month, the print landing in line with that bullish run-up, and analysts moving targets higher on the day of the release.

The post-earnings options picture has normalised, but not reverted. The put/call ratio was running at roughly 0.02 across late October, the most call-heavy reading in a year, as covered in the pre-earnings note. It has since edged up to 0.10, still well below the 20-day mean of 0.21 and below the midpoint of its 52-week range of 0.02 to 1.39. Call volume has settled from its extreme but the market has not pivoted to hedging. The stock closed at $122.54, essentially flat on the week after a 3.1% gain on October 30 alone.

The analyst reaction to the print was swift and broadly constructive. JP Morgan's Kenneth Worthington raised his target to $137 from $136, maintaining Overweight. Wells Fargo lifted to $133 from $125. Barclays moved to $135 from $130, holding Equal-Weight. Those three moves all landed on October 30, the day after the release. The Street's mean target now sits at $129.33, about 6% above the close, with Overweight ratings from JP Morgan and Wells Fargo on one side and Equal-Weight from Barclays and Morgan Stanley on the other. TD Cowen remains at Hold with a $107 target, the clearest outlier in the group. The bulls point to the 17% year-over-year January revenue growth and the beat on adjusted expenses in Q4 2025; the bears flag regulatory risk under MiFID II and CFTC oversight, and the threat from better-priced electronic trading entrants.

Short interest is a non-story this week, and that is itself informative. Shorts have pulled back steadily, falling roughly 8% over the week to 2.7% of the free float, the lowest level in the 30-day window. The borrow market is entirely relaxed: availability is at maximum levels, cost to borrow is 0.49%, and the lending pool is barely touched. There is no squeeze pressure and no sign that sceptics are adding to positions into strength. The ORTEX short score sits at 32.4, towards the lower end of its recent range, consistent with a name that bears are exiting rather than building.

The ownership structure is worth noting for context. Refinitiv Parent Limited, now part of the London Stock Exchange Group, holds a 50.8% stake per a Schedule 13D/A filed in March 2025. That filing carries an activist classification, though the stake reflects LSEG's strategic ownership rather than a traditional activist campaign. T. Rowe Price holds 13.6% as disclosed in February 2026, up from 10.4% previously, and has continued adding on the institutional side with a further 1.34 million shares added to its position as of September 30. Carmignac added 1.59 million shares as of June. The ownership base is concentrated and has been moving in one direction. As always, 13D/G stakes are event-driven disclosures around the 5% threshold and positions may have moved since last filing.

Separately, retail attention has picked up. Wikipedia views for Tradeweb are running at a z-score of 2.45 relative to the prior 90 days, based on ORTEX Alt Data from Wikimedia Foundation as of October 21. That is attention tracking, not a revenue signal, but the timing coincides with the earnings run-up and the volume of analyst activity. The next earnings event is scheduled for February 4, 2027, giving the Street 96 days to decide whether the post-earnings target cluster around $130 to $137 is a ceiling or a floor.

What to watch now is whether the options market stays call-heavy as the stock digests its gains, and whether the JP Morgan and Wells Fargo target lifts pull the consensus mean meaningfully higher over the next few weeks, or whether the Equal-Weight contingent at Barclays and Morgan Stanley begins to constrain the re-rating.